Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


CEO of Twist Bioscience, Emily Leproust, sold 1,654 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

  • On December 20, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 1,654 shares of common stock at a price of $44.903 per share.
  • The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units.
  • Following the transaction, Leproust directly owns 673,064 shares of Twist Bioscience common stock.
  • Leproust also holds options to purchase Twist Bioscience common stock at various exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document is a standard Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations are a routine part of equity compensation plans for executives at publicly traded companies.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
09/01/201625% of shares subject to one employee stock option vested
09/28/201710% of shares subject to one employee stock option vested
09/28/201815% of shares subject to one employee stock option vested
10/31/201920% of shares subject to one employee stock option vested
10/24/202025% of shares subject to one employee stock option vested
09/01/2020Performance stock options granted to the reporting person
12/19/2022Performance stock options vested and became exercisable
12/20/2024Emily Leproust sold 1,654 shares of Twist Bioscience common stock
08/31/2030Expiration date of one employee stock option

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.